112 related articles for article (PubMed ID: 17616803)
1. Matrix metalloproteinase (MMP)-2 and MMP-9 in seminal plasma.
Tentes I; Asimakopoulos B; Mourvati E; Diedrich K; Al-Hasani S; Nikolettos N
J Assist Reprod Genet; 2007 Jul; 24(7):278-81. PubMed ID: 17616803
[TBL] [Abstract][Full Text] [Related]
2. Detection of matrix metalloproteinase (MMP)-2 and MMP-9 in canine seminal plasma.
Saengsoi W; Shia WY; Shyu CL; Wu JT; Warinrak C; Lee WM; Cheng FP
Anim Reprod Sci; 2011 Aug; 127(1-2):114-9. PubMed ID: 21824735
[TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinases in mild and severe temporomandibular joint internal derangement synovial fluid.
Srinivas R; Sorsa T; Tjäderhane L; Niemi E; Raustia A; Pernu H; Teronen O; Salo T
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 May; 91(5):517-25. PubMed ID: 11346728
[TBL] [Abstract][Full Text] [Related]
4. Complexes of gelatinases and tissue inhibitor of metalloproteinases in human seminal plasma.
Shimokawa K; Katayama M; Matsuda Y; Takahashi H; Hara I; Sato H
J Androl; 2003; 24(1):73-7. PubMed ID: 12514086
[TBL] [Abstract][Full Text] [Related]
5. Matrix metalloproteinase 2 and 9 activity in patients with colorectal cancer liver metastasis.
Waas ET; Wobbes T; Lomme RM; DeGroot J; Ruers T; Hendriks T
Br J Surg; 2003 Dec; 90(12):1556-64. PubMed ID: 14648736
[TBL] [Abstract][Full Text] [Related]
6. Matrix metalloproteinase (MMP)-2 and MMP-9 activities in human seminal plasma.
Shimokawa Ki K; Katayama M; Matsuda Y; Takahashi H; Hara I; Sato H; Kaneko S
Mol Hum Reprod; 2002 Jan; 8(1):32-6. PubMed ID: 11756567
[TBL] [Abstract][Full Text] [Related]
7. Matrix metalloproteinase-2 and -9 in bile as a marker of liver metastasis in colorectal cancer.
Okada N; Ishida H; Murata N; Hashimoto D; Seyama Y; Kubota S
Biochem Biophys Res Commun; 2001 Oct; 288(1):212-6. PubMed ID: 11594775
[TBL] [Abstract][Full Text] [Related]
8. Presence of matrix metalloproteinases and tissue inhibitor of matrix metalloproteinase in human sperm.
Buchman-Shaked O; Kraiem Z; Gonen Y; Goldman S
J Androl; 2002; 23(5):702-8. PubMed ID: 12185105
[TBL] [Abstract][Full Text] [Related]
9. Enhanced production and activation of progelatinase A mediated by membrane-type 1 matrix metalloproteinase in human papillary thyroid carcinomas.
Nakamura H; Ueno H; Yamashita K; Shimada T; Yamamoto E; Noguchi M; Fujimoto N; Sato H; Seiki M; Okada Y
Cancer Res; 1999 Jan; 59(2):467-73. PubMed ID: 9927064
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of MMP-2 and MMP-9 in patients with oral cancer.
Patel BP; Shah SV; Shukla SN; Shah PM; Patel PS
Head Neck; 2007 Jun; 29(6):564-72. PubMed ID: 17252594
[TBL] [Abstract][Full Text] [Related]
11. Expression of latent matrix metalloproteinase 9 (MMP-9) predicts survival in advanced ovarian cancer.
Lengyel E; Schmalfeldt B; Konik E; Späthe K; Härting K; Fenn A; Berger U; Fridman R; Schmitt M; Prechtel D; Kuhn W
Gynecol Oncol; 2001 Aug; 82(2):291-8. PubMed ID: 11531282
[TBL] [Abstract][Full Text] [Related]
12. Identification of ocular matrix metalloproteinases present within the aqueous humor and iridocorneal drainage angle tissue of normal and glaucomatous canine eyes.
Weinstein WL; Dietrich UM; Sapienza JS; Carmichael KP; Moore PA; Krunkosky TM
Vet Ophthalmol; 2007; 10 Suppl 1():108-16. PubMed ID: 17973842
[TBL] [Abstract][Full Text] [Related]
13. Membrane-type 1 matrix metalloproteinase-mediated progelatinase A activation in non-tumorigenic and tumorigenic human keratinocytes.
Baumann P; Zigrino P; Mauch C; Breitkreutz D; Nischt R
Br J Cancer; 2000 Nov; 83(10):1387-93. PubMed ID: 11044366
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of plasma activity of matrix metalloproteinase-2 and -9 in dogs with myxomatous mitral valve disease.
Ljungvall I; Rajamäki MM; Crosara S; Olsen LH; Kvart C; Borgarelli M; Höglund K; Häggström J
Am J Vet Res; 2011 Aug; 72(8):1022-8. PubMed ID: 21801058
[TBL] [Abstract][Full Text] [Related]
15. Matrix metalloproteinase (MMP)-2, MMP-9, semen quality and sperm longevity in fractionated stallion semen.
Kareskoski M; Vakkamäki J; Laukkanen K; Palviainen M; Johannisson A; Katila T
Theriogenology; 2021 Apr; 164():93-99. PubMed ID: 33571920
[TBL] [Abstract][Full Text] [Related]
16. Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human invasive breast carcinomas.
Ueno H; Nakamura H; Inoue M; Imai K; Noguchi M; Sato H; Seiki M; Okada Y
Cancer Res; 1997 May; 57(10):2055-60. PubMed ID: 9158005
[TBL] [Abstract][Full Text] [Related]
17. Autoactivation profiles of calcium-dependent matrix metalloproteinase-2 and -9 in inflammatory synovial fluid: effect of pyrophosphate and bisphosphonates.
Makowski GS; Ramsby ML
Clin Chim Acta; 2005 Aug; 358(1-2):182-91. PubMed ID: 15921672
[TBL] [Abstract][Full Text] [Related]
18. Activation of MMP-2 and MMP-9 in patients with oral squamous cell carcinoma.
Patel BP; Shah PM; Rawal UM; Desai AA; Shah SV; Rawal RM; Patel PS
J Surg Oncol; 2005 May; 90(2):81-8. PubMed ID: 15844188
[TBL] [Abstract][Full Text] [Related]
19. Matrix metalloproteinase-2 and -9 activity levels increase in cutaneous lupus erythematosus lesions and correlate with disease severity.
Ertugrul G; Keles D; Oktay G; Aktan S
Arch Dermatol Res; 2018 Mar; 310(2):173-179. PubMed ID: 29349515
[TBL] [Abstract][Full Text] [Related]
20. Levels of matrix metalloproteinase-2, -9 and -8 in the skin, serum and saliva of smokers and non-smokers.
Raitio A; Tuomas H; Kokkonen N; Salo T; Sorsa T; Hanemaaijer R; Oikarinen A
Arch Dermatol Res; 2005 Dec; 297(6):242-8. PubMed ID: 16215764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
